>
产品中心 >
Other_reagents >
Adipogen/ODN 1826 (Type B) Endotoxin-free (sterile)/IAX-200-002-M001/1 mg

ProductDetails | |
---|---|
Synonyms | CpGODNTLR9AgoNIST:BType(species:rodent) |
ProductType | Chemical |
Properties | |
MW | 6,383g/mol |
Sequence | 5"-tccatgacgttcctgacgtt-3"(lowercaseletters:phosphorothioatelinkage:nucleaseresistant). |
Reconstitution | Fora100μMstocksolution,dissolvetotalvialcontentin1570μl(1mgsize)or157μl(100μgsize)sterileendotoxin-freewaterorPBS. |
Formulation | Lyophilized.Sterile. |
BIOLOGicalActivity | Optimalconcentrationisdependentuponcelltype,species,desiredactivationandanalysis:invitro0.1-1μM(~0.6-6.0μg/ml);invivo50-250μginrodentanimalmodels. |
Crossreactivity | Mouse Rat |
Specificity | Mouse,Rat |
EndotoxinContent | <0.002eu g="">0.002eu> |
Declaration | ManufacturedbyInnaxon. |
OtherProductData | Contains:100μgsizeincludes1.5mlddWaterEndotoxin-free(sterile)(Cat.No.:IAX-900-002-LD15).1mgand3x1mgsizeseachinclude10mlddWaterEndotoxin-free(sterile)(Cat.No.:IAX-900-002-L010). |
ShippingandHandling | |
Shipping | AMBIENT |
ShortTermStorage | +4°C |
LongTermStorage | +4°C |
HandlingAdvice | Avoidfreeze/thawcycles. Afterreconstitution,preparealiquotsandkeepaqueousstocksolutionsfor1dayat4°Corstoreat-20°C(shelf-life6months). |
Use/StABIlity | Stableforatleast2yearsafterreceiptwhenstoredat+4°C. |
Documents | |
MSDS | ![]() |
ProductSpecificationSheet | |
Datasheet | ![]() |
UnmethylatedCGdinucleotideswithinparticularsequencecontextsareresponsIBLefortheimmunostimulatoryactivityofbacterialDNA.Syntheticoligonucleotides(ODN)thatcontainsuchCpGmotifs(CpGODNs)mimicmicrobialDNA.TheinnateimmunesystemofvertebrateshastheabilitytorecognizeCpGmotifsinmicrobialDNAviatheToll-likereceptor(TLR)9iftheCpGODNwerefreeofadditionalimmunestimulatorycontaminantsoftenpresentinsyntheticcommercialCpGODNpreparationsdesignedformolecularbiologyapplications(i.e.PCR).GiventhathighqualityCpGODNswereused[i.e.endotoxin-free],acloselinkhasbeenestablishedbetweentheexpressionofTLR9oncertainimmunecellsubsetsandthemodulationoftheimmunesystembyCpGDNA.DifferenttypesofCpGODNswereidentifiedbasedontheirdifferingbiologicaleffectsondifferentcelltypes:ODNTypeAisapotentinducerofIFN-αinhumanPDC,(i.e.ODN1585or2216)leADIngtoantigenpresentingcell(APC)maturation,whereasODNTypeB(i.e.ODN2006orODN1668/ODN1826)isaweakinducerofIFN-αbutratherstimulatesIL-8productionandincreasingcostimulatoryandAg-presentingmoleculesandtriggersproliferationofB-cellsandIgMandIL-6production.AthirdtypeofCpGODNhasbeenidentified,termedODNTypeC,withbothhighinductionofINF-αinPDCandactivationofB-cells.ThesequenceofCpGTypeC(alsocalledK)(i.e.ODN2395orM362)combineselementsofbothTypeAandTypeBandcontainsacentralpalindromicsequencewithCGdinucleotides,acharacteristicfeatureofTypeA,andaTCGTCGmotifatthe5"end,presentinTypeBCpGODNs.AlthoughtheCpGmotifsarethoughttodifferbetweenmiceandhumans,inbothspeciestherecognitionofCpGODNsismediatedbyTLR9.TheoptimalCpGmotifinhumansisGTCGTTandGACGTTforthemurinesequence.However,recentevidencesuggeststhatthissequencespecificityisrestrictedtophosphorothioate(PS)-modifiedODNandisnotobservedwhenanaturalphosphodiesterbackboneisused.Inrecentyearssequencerequirements,specificity,signalingpathwaysandkineticsoftheTLR9suppressionbyinhibitoryODNs(iODNs)havebeeninvestigated.
- ComparisonofdifferentCpGoligodeoxynucleotideclassesfortheircapabilitytostimulatehumanNKcells:S.Sivori,etal.;Eur.J.Immunol.36,961(2006)
- InnateimmuneresponsesinducedbyclassesofCpGoligodeoxynucleotidesinovinelymphnodeandbloodmononuclearcells:J.S.Booth,etal.;Vet.Immunol.Immunopathol.115,24(2007)
- ImpactofclassA,BandCCpG-oligodeoxynucleotidesoninvitroactivationofinnateimmunecellsinhumanimmunodeficiencyvirus-1infectedindividuals:J.A.Martinson,etal.;Immunology120,526(2007)
- ThreeCpGoligodeoxynucleotideclassesdifferentiallyenhanceantigen-specifichumoralandcellularimmuneresponsesinmice:Y.Liu,etal.;Vaccine29,5778(2011)
- Toll-likereceptorandIL-12signalingcontrolsusceptibilitytocontacthypersensitivity:S.F.Martin,etal.;J.Exp.Med.205,2151(2008)